| View |
|
DRP-4115-03
|
Aluminum Hydroxide + Magnesium Hydroxide
|
None
|
200 mg/100 mg
|
Chewable Tablet
|
Antacid
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 August 2024
|
23 November 2027
|
| View |
|
DRP-4210-05
|
Ferrous Sulfate + Folic Acid + Vitamin B Complex
|
Trev Iron FAB
|
(See formulation on reverse side)
|
Capsule
|
Hematinic
|
Lifesquare Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
03 August 2024
|
07 February 2025
|
| View |
|
DRP-4335-07
|
Fluconazole
|
Ziludex
|
150 mg
|
Capsule
|
Antifungal
|
Bal Pharma Limited (Unit-I)
|
India
|
CLIDP Conversion
|
04 August 2024
|
27 March 2028
|
| View |
|
DRP-4373-09
|
Amlodipine (as besilate)
|
Amlodipex
|
5 mg
|
Tablet
|
Calcium Channel Blocker
|
Scheele Laboratories Phils. Inc
|
Philippines
|
CLIDP Conversion
|
04 August 2024
|
28 March 2026
|
| View |
|
DRP-4857-04
|
Cefuroxime (as axetil)
|
None
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Sunlovis Pharmaceuticals LLP
|
India
|
CLIDP Conversion
|
04 August 2024
|
24 October 2028
|
| View |
|
DRP-5020-03
|
Celecoxib
|
Maedicoxib
|
400 mg
|
Capsule
|
Selective COX-2 Inhibitor
|
Lifesquare Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
25 July 2024
|
22 September 2026
|
| View |
|
DRP-5052-30
|
Cefixime (As Trihydrate)
|
Bexime
|
100 mg/5 mL
|
Granules for Suspension
|
Antibacterial (Third Generation Cephalosporin)
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
03 August 2024
|
18 August 2027
|
| View |
|
DRP-5087-09
|
Racecadotril
|
Rcad-S
|
30 mg/sachet
|
Powder for Oral Suspension
|
Anti-diarrheal
|
XL Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
04 August 2024
|
11 February 2029
|
| View |
|
DRP-5421-09
|
Telmisartan
|
Micargen
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Healer's Lab. Unit II
|
India
|
CLIDP Conversion
|
25 July 2024
|
05 August 2029
|
| View |
|
DRP-5421-10
|
Telmisartan
|
None
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Healer's Lab. Unit II
|
India
|
CLIDP Conversion
|
25 July 2024
|
08 August 2029
|
| View |
|
DRP-5683-28
|
Cefixime
|
Cefegold
|
20mg/mL
|
Granules For Suspension (Oral Drops)
|
Antibacterial (Cephalosporin)
|
J.M. Tolmann Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
03 August 2024
|
20 February 2029
|
| View |
|
DRP-5924-04
|
Clarithromycin
|
Klarifer-250
|
250 mg per 5 mL
|
Granules for Suspension
|
Antibacterial
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
06 August 2024
|
05 January 2025
|
| View |
|
DRP-6051-22
|
Ketoanalogues + Essential Amino Acids
|
RenaClone-E
|
(See Reverse for Unit Dose Formulation)
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 August 2024
|
13 March 2030
|
| View |
|
DRP-15497
|
Omeprazole (as sodium)
|
Omebel
|
40 mg
|
Lyophilized Powder for IV Injection
|
Proton Pump Inhibitor
|
Om Biomedic Pvt. Ltd.
|
India
|
Initial
|
26 July 2024
|
26 July 2029
|
| View |
|
DRP-15496
|
Omeprazole (as sodium)
|
Blicid
|
40 mg
|
Lyophilized Powder for IV Injection
|
Proton Pump Inhibitor
|
Om Biomedic Pvt. Ltd.
|
India
|
Initial
|
26 July 2024
|
26 July 2029
|
| View |
|
DRP-15495
|
Omeprazole (as sodium)
|
Omcid
|
40 mg
|
Lyophilized Powder for IV Injection
|
Proton Pump Inhibitor
|
Om Biomedic Pvt. Ltd.
|
India
|
Initial
|
26 July 2024
|
26 July 2029
|
| View |
|
DRP-15503
|
Amlodipine (as Besylate) + Valsartan ++
Hydrochlorothiazide
|
Amizide-V
|
5 mg/160 mg/12.5 mg
|
Film-Coated Table
|
Antihypertensive
|
Medisure Laboratories Pakistan (Pvt.) Ltd.
|
Pakistan
|
Initial
|
30 July 2024
|
30 July 2029
|
| View |
|
DR-XY49139
|
Dapagliflozin
|
Dapazin
|
10 mg
|
Film-Coated Tablet
|
Blood Glucose Lowering Drug
(Sodium-glucose co-transporter 2 (SGLT2) inhibitor).
|
Ajanta Pharma Limited
|
India
|
Initial
|
26 July 2024
|
26 July 2029
|
| View |
|
DRP-15504
|
Pemetrexed (as disodium hemipentahydrate)
|
Pemtero 500
|
500 mg
|
Lyophilized Powder for IV Infusion
|
Antineoplastic
|
Hetero Labs Limited (Unit VI)
|
India
|
Initial
|
30 July 2024
|
30 July 2029
|
| View |
|
DRP-15505
|
Pemetrexed (as disodium hemipentahydrate)
|
Pemtero 100
|
100 mg
|
Lyophilied Powder for IV Infusion
|
Antineoplastic
|
Hetero Labs Limited (Unit VI)
|
India
|
Initial
|
30 July 2024
|
30 July 2029
|